Perkins Capital Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Perkins Capital Management’s Portfolio NMTC Stock Details NMTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$744K	Sell	244,656 -844	-0.3%	-$3.45K	0.56%	43
2026 Q1	$1.14M	Hold	245,500	–	–	1.07%	28
2025 Q4	$1.12M	Buy	245,500 +833	+0.3%	+$3.79K	0.89%	36
2025 Q3	$1.3M	Sell	244,667 -5,333	-2%	-$26.1K	1.15%	26
2025 Q2	$1.02M	Buy	+250,000	New	+$923K	1.02%	31
2024 Q4	–	Sell	-25,000	Closed	-$149K	–	86
2024 Q3	$149K	Hold	25,000	–	–	0.14%	75
2024 Q2	$120K	Hold	25,000	–	–	0.11%	80
2024 Q1	$180K	Hold	25,000	–	–	0.15%	81
2023 Q4	$237K	Hold	25,000	–	–	0.2%	80
2023 Q3	$134K	Buy	+25,000	New	+$167K	0.13%	86

Other funds holding NMTC

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Perkins Capital Management's NMTC Position: Q2 2026 in Review

Perkins Capital Management reduced its NeuroOne Medical Technologies (NMTC) stake by 0.34% in Q2 2026, selling an estimated $3.45K and leaving 244,656 shares worth $744K. The position accounts for 0.56% of the portfolio, ranked #43.

Perkins Capital Management first reported a position in NMTC in Q3 2023 and has held it in 10 quarters since. The position peaked at $1.3M in Q3 2025. 26 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

Perkins Capital Management held 244,656 shares of NeuroOne Medical Technologies worth $744K as of Q2 2026.
Perkins Capital Management sold 844 NeuroOne Medical Technologies shares in Q2 2026, an estimated $3.45K.
NeuroOne Medical Technologies made up 0.56% of Perkins Capital Management's portfolio in Q2 2026, its #43 holding.
Perkins Capital Management first reported a position in NeuroOne Medical Technologies in Q3 2023 and has held it in 10 quarters since.
Perkins Capital Management's NeuroOne Medical Technologies position peaked at $1.3M in Q3 2025.
26 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Perkins Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.